Vet a pharmacist in five minutes.
Public-record verification on any US pharmacist. CMS NPI Registry, OIG LEIE federal exclusion check, state pharmacy boards, NABP cross-state record, BPS specialty certification, ASHP Fellow record, plus the FDA 503A/503B compounding-inspection record for compounding pharmacists. Twelve sections, every claim cited.
What gets verified
Every Pharmacist Vetting Report draws from the regulator-of-record sources for the US pharmacy profession. Where a section's source is silent on the subject, the section degrades gracefully with an explicit "no public regulatory concerns" or insufficient-evidence tag rather than padding with guesses.
| Source | What it tells us |
|---|---|
| CMS NPI Registry | Verified identity, primary taxonomy (pharmacist subspecialties), practice address(es), enumeration date, NPI status, RPh / PharmD credential. |
| OIG LEIE | Federal exclusion from Medicare / Medicaid programs. A positive match here is dispositive. |
| State pharmacy boards (top 12) | State licensure status, disciplinary actions of record. Each state has its own lookup URL, surfaced directly so verification of record is one click away. |
| NABP | National Association of Boards of Pharmacy — cross-state license verification, e-Profile, MPJE / CPJE record. |
| BPS | Board of Pharmacy Specialties — board certification across 14 specialties (pharmacotherapy, oncology, infectious diseases, geriatrics, sterile compounding, and more). |
| ASHP / APhA | American Society of Health-System Pharmacists Fellow status (FASHP), accredited residency record. APhA membership and fellow designation. |
| FDA 503A/503B | Compounding pharmacist FDA inspection records. Vetter-unique data source — only relevant for compounding pharmacists. |
| PCAB | Pharmacy Compounding Accreditation Board — accreditation status for compounding pharmacies. |
| PubMed + NIH iCite | Publication and citation record for clinical-pharmacy and pharmacy-informatics research. |
What the report contains
The full Pharmacist Vetting Report is twelve sections, paginated, between 2,500 and 5,500 words depending on the subject's regulatory and practice footprint. Each section ends with its source citations.
- Executive Summary. 200-400 word synthesis. The fast-read for a credentialing reviewer who has 90 seconds.
- Identity and Credentials. Verified-identity record from NPI Registry plus state pharmacy board licensure. RPh / PharmD credential, enumeration date, primary taxonomy.
- Specialty Certification and Practice Profile. BPS Diplomate status across the 14 BPS specialties. ASHP Fellow / residency record. Practice setting (chain / independent / hospital / clinical / compounding).
- License and Disciplinary History. The single highest-stakes section. Leads with OIG LEIE result. State pharmacy board lookup URL surfaced for direct verification. NABP cross-state record when available.
- Publication and Research Record. PubMed total publications, iCite h-index proxy, NIH grants, top-cited works. Most clinical pharmacists publish little — degrades to "consistent with clinical-practice focus".
- FDA Compounding and Inspection Record. For pharmacists involved in 503A or 503B compounding, the FDA inspection database surfaces inspection dates, Form 483 observations, warning letters, import alerts. Reported as inspection-record data, never as adjudicated misconduct.
- Practice Affiliations and Setting. Practice locations from NPI record. PCAB-accredited compounding pharmacies surface here when the subject is affiliated.
- Comparable Pharmacists. Five archetype-matched peers from a curated reference. Composite scoring on specialty, practice setting, career stage.
- Public Reputation and Patient Sentiment. Yelp + Google review aggregation for the practice (where applicable).
- Malpractice Surface. CourtListener civil malpractice case search with pharmacy-specific terms. Bounded by strong defamation disclaimers.
- Network and Professional Connections. PubMed co-authorship graph. ASHP fellow co-listings. BPS specialty cohort connections.
- References and Source Citations. Full audit trail. Every URL cited across the prior eleven sections, deduplicated and grouped by source class.
How we identify the right pharmacist
NPI is the canonical identifier for pharmacist subjects. We solve same-name disambiguation with three independent gates.
Gate 1 — NPI Registry candidate match
The NPI Registry name search restricted to pharmacist taxonomy (183500000X) must return a candidate before the report can run. NPI is the canonical identifier; 10-digit NPI input goes straight to the verified record.
Gate 2 — Disambiguation card
Multiple candidates surface as a disambiguation card with city, sub-specialty taxonomy, practice setting, and primary state. The buyer picks the right person before any synthesis runs.
Gate 3 — Confirm before charge
Even when only one candidate scores high enough, we still surface the candidate card for explicit confirmation before charging credits.
Defamation guardrails
State licensure facts are quoted only from the board's own public record. Form 483 observations are reported as inspection observations, not as adjudicated wrongdoing. CourtListener civil filings are framed as litigation activity.
Sample report on file
Public sample report curated for the pharmacist vertical. Built from public-record sources only.
Sample illustrates the NPI-verified identity layer, OIG LEIE check, state board licensure trail, and BPS specialty cert verification.
When to use a Pharmacist Vetting Report
- Self-verification. Pharmacists assembling credentialing packets for PBM panels, hospital pharmacy committees, multi-state license renewals, BPS specialty board cert applications, Medicaid / Medicare provider enrollment.
- Hospital pharmacy committee credentialing. Health systems credentialing clinical pharmacists, pharmacy directors, and consultant pharmacists annually as part of medical-staff review.
- Pharmacy chain hiring. CVS, Walgreens, Walmart, Costco, Kroger pharmacy chains hiring at scale.
- Patient research for compounding pharmacies. Patients selecting between compounding pharmacies want assurance the pharmacy has a clean state board record, no FDA compounding violations, and the pharmacist holds appropriate specialty cert.
- 503B outsourcing facility due diligence. Hospital systems contracting with 503B outsourcing facilities use the report to surface FDA inspection history, Form 483 observations, and warning letters.
Pricing
Pharmacist Snapshot
One-page verification. Fast credentialing pricing.
10 credits
- NPI Registry verification + RPh / PharmD credential
- OIG LEIE federal exclusion check
- State pharmacy board licensure headline
- BPS specialty certification headline
- Source URL audit trail
- Returns in roughly 60 seconds
Pharmacist Vetting Report Recommended
Full verification. Twelve sections, paginated PDF.
50 credits
- All twelve sections, 2,500-5,500 words
- FDA 503A/503B inspection record (vetter-unique)
- BPS Diplomate status across 14 specialties
- NABP cross-state license trail
- PubMed publication + iCite citation record
- References section: every cited regulator URL
- Returns in 4-5 minutes
Credits are platform-wide. A Pro plan includes credits monthly; pay-as-you-go credit packs are available. See pricing for current plans.
Methodology
The full methodology behind the Pharmacist Vetting Report is published. It covers the NPI hard gate, the four-class source taxonomy, the UK PHIA Probability Yardstick used for confidence statements, defamation guardrails, the FDA compounding inspection methodology, and what the report explicitly does not do.
Frequently asked questions
What sources does the Pharmacist Vetting Report draw from?
CMS NPI Registry, OIG LEIE federal exclusion list, state pharmacy boards across the top 12 jurisdictions, NABP for cross-state license verification, Board of Pharmacy Specialties for specialty certification, ASHP for Fellow / residency record, FDA 503A/503B for compounding pharmacists, PCAB for compounding-pharmacy accreditation, PubMed for publication record.
Why is the FDA 503A/503B inspection record vetter-unique?
The FDA's compounding inspection database surfaces inspection dates, Form 483 observations, warning letters, and import alerts for compounding pharmacists. No other vetter we know of integrates this data source.
Is this a substitute for state pharmacy board verification of record?
No. The report cites the state pharmacy board's lookup URL directly so the reader can verify licensure at the source of record.
What about DEA registration data?
DEA registration is not publicly searchable. The report does not surface DEA registration numbers, DEA status, or controlled-substance prescribing patterns.
Does the report cover the Open Payments / Sunshine Act database?
No. The Sunshine Act covers physicians, dentists, podiatrists, optometrists, chiropractors, and APRNs / PAs only. Pharmacists are not a covered recipient.
Can patients use this when choosing a compounding pharmacy?
Yes. The patient-research mode tunes the headline toward consumer signals: state licensure status, BPS Sterile Compounding cert, FDA 503A/503B inspection record, PCAB accreditation status, and any state-board disciplinary history.
Related
Physician Vetting Reports → Veterinarian Vetting Reports → Use case: Checking a Physician → Methodology: Pharmacist →